Paradigm Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.7K | Hold |
|
|||||
|
2025
Q1 | $26.5K | Hold |
|
|||||
|
2024
Q4 | $32.5K | Hold |
|
|||||
|
2024
Q3 | $34.7K | Hold |
|
|||||
|
2024
Q2 | $36.4K | Hold |
|
|||||
|
2024
Q1 | $47.7K | Hold |
|
|||||
|
2023
Q4 | $41.6K | Hold |
|
|||||
|
2023
Q3 | $34.5K | Hold |
|
|||||
|
2023
Q2 | $37K | Hold |
|
|||||
|
2023
Q1 | $35.5K | Hold |
|
|||||
|
2022
Q4 | $38.4K | Sell |
|
|||||
|
2022
Q3 | $546K | Hold |
|
|||||
|
2022
Q2 | $594K | Hold |
|
|||||
|
2022
Q1 | $788K | Hold |
|
|||||
|
2021
Q4 | $1.05M | Buy |
|
|||||
|
2021
Q3 | $1.07M | Sell |
|
|||||
|
2021
Q2 | $999K | Hold |
|
|||||
|
2021
Q1 | $783K | Sell |
|
|||||
|
2020
Q4 | $700K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $132K | Hold |
|
|||||
|
2016
Q1 | $122K | Sell |
|
|||||
|
2015
Q4 | $378K | Buy |
|